TrialInternational immunopharmacology2021

Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial.

Saghar Barati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.